Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis
- 1 July 2010
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 139 (1) , 335-343.e2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell FeaturesGastroenterology, 2009
- Liver stem cells and hepatocellular carcinoma†Hepatology, 2008
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin?The American Journal of Pathology, 2008
- Different types of liver progenitor cells and their nichesJournal of Hepatology, 2006
- Liver pathology and hepatocarcinogenesis in a long‐term mouse model of erythropoietic protoporphyriaThe Journal of Pathology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988